Published in J Chromatogr B Analyt Technol Biomed Life Sci on February 05, 2005
Human body fluid proteome analysis. Proteomics (2006) 2.39
High dynamic range characterization of the trauma patient plasma proteome. Mol Cell Proteomics (2006) 2.25
Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol Cell Proteomics (2006) 2.14
Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways? Am J Physiol Lung Cell Mol Physiol (2008) 1.55
Calgranulin B (S100A9) levels in bronchoalveolar lavage fluid of patients with interstitial lung diseases. Inflammation (2008) 1.48
Pulmonary biomarkers based on alterations in protein expression after exposure to arsenic. Environ Health Perspect (2007) 1.08
Application of glycoproteomics for the discovery of biomarkers in lung cancer. Proteomics Clin Appl (2012) 0.93
Modulation of gene expression in Actinobacillus pleuropneumoniae exposed to bronchoalveolar fluid. PLoS One (2009) 0.92
Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. Arthritis Res Ther (2006) 0.86
Molecular analysis of serum and bronchoalveolar lavage in a mouse model of influenza reveals markers of disease severity that can be clinically useful in humans. PLoS One (2014) 0.85
malT knockout mutation invokes a stringent type gene-expression profile in Actinobacillus pleuropneumoniae in bronchoalveolar fluid. BMC Microbiol (2009) 0.85
Phosphoproteome Discovery in Human Biological Fluids. Proteomes (2016) 0.84
The thioredoxin system in neonatal lung disease. Antioxid Redox Signal (2014) 0.83
Proteomic analysis of human bronchoalveolar lavage fluid after subsgemental exposure. J Proteome Res (2013) 0.83
Glycoproteomics using fluid-based specimens in the discovery of lung cancer protein biomarkers: promise and challenge. Proteomics Clin Appl (2013) 0.82
Characterization of the phosphoproteome in human bronchoalveolar lavage fluid. Int J Proteomics (2012) 0.81
Shotgun MS proteomic analysis of bronchoalveolar lavage fluid in normal subjects. Proteomics Clin Appl (2014) 0.81
Expression of calgranulin A/B heterodimer after acute inhalation of endotoxin: proteomic approach and validation. BMC Pulm Med (2013) 0.80
Use of anchorchip-time-of-flight spectrometry technology to screen tumor biomarker proteins in serum for small cell lung cancer. Diagn Pathol (2010) 0.79
Metabolic Consequences of Chronic Alcohol Abuse in Non-Smokers: A Pilot Study. PLoS One (2015) 0.78
Outcome prediction in pneumonia induced ALI/ARDS by clinical features and peptide patterns of BALF determined by mass spectrometry. PLoS One (2011) 0.78
Barriers to inhaled gene therapy of obstructive lung diseases: A review. J Control Release (2016) 0.77
Cholesteryl esters are elevated in the lipid fraction of bronchoalveolar lavage fluid collected from pediatric cystic fibrosis patients. PLoS One (2015) 0.77
Inactivation of Peroxiredoxin 6 by the Pla Protease of Yersinia pestis. Infect Immun (2015) 0.77
Airway proteins involved in bacterial clearance susceptible to cathepsin G proteolysis. Eur Respir J (2009) 0.76
Mass Spectrometry-based Proteomics in Acute Respiratory Distress Syndrome: A Powerful Modality for Pulmonary Precision Medicine. Chin Med J (Engl) (2016) 0.76
Integrating omics technologies to study pulmonary physiology and pathology at the systems level. Cell Physiol Biochem (2014) 0.76
Characterization of protein factor(s) in rat bronchoalveolar lavage fluid that enhance insulin transport via transcytosis across primary rat alveolar epithelial cell monolayers. Eur J Pharm Biopharm (2008) 0.76
Application of clinical proteomics in acute respiratory distress syndrome. Clin Transl Med (2014) 0.75
Comparative Proteomic Analysis of Rat Bronchoalveolar Lavage Fluid after Exposure to Zinc Oxide Nanoparticles. Mass Spectrom (Tokyo) (2017) 0.75
Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae. Infect Immun (1987) 4.92
Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG. Microb Pathog (1987) 2.66
Purification, partial characterization, and identification of a skin-reactive protein antigen of Mycobacterium bovis BCG. Infect Immun (1987) 2.12
Cloning and characterization of AOEB166, a novel mammalian antioxidant enzyme of the peroxiredoxin family. J Biol Chem (1999) 1.28
Primary and quaternary structure of the catabolic ornithine carbamoyltransferase from Pseudomonas aeruginosa. Extensive sequence homology with the anabolic ornithine carbamoyltransferases of Escherichia coli. Eur J Biochem (1987) 1.19
Anabolic ornithine carbamoyltransferase of Pseudomonas aeruginosa: nucleotide sequence and transcriptional control of the argF structural gene. J Bacteriol (1988) 1.16
Secondary structure of diphtheria toxin and its fragments interacting with acidic liposomes studied by polarized infrared spectroscopy. J Biol Chem (1989) 1.10
Primary structure of diphtheria toxin fragment B: structural similarities with lipid-binding domains. J Cell Biol (1980) 1.09
Gene cloning, sequence analysis, purification, and characterization of a thermostable aminoacylase from Bacillus stearothermophilus. Appl Environ Microbiol (1993) 1.06
Localization in diphtheria toxin fragment B of a region that induces pore formation in planar lipid bilayers at low pH. FEBS Lett (1983) 1.05
Structure-activity relationships of the B fragment of diphtheria toxin: the lipid-binding domains. Toxicon (1982) 1.04
The complete amino acid sequence of diphtheria toxin fragment B. Correlation with its lipid-binding properties. Biochim Biophys Acta (1985) 0.97
Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability. Eur Respir J (1999) 0.96
Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases. Electrophoresis (2000) 0.96
Purification and characterization of a bovine pregnancy-associated glycoprotein. Biol Reprod (1991) 0.94
A CNBR peptide located in the middle region of diphtheria toxin fragment B induces conductance change in lipid bilayers. Possible role of an amphipathic helical segment. Biochem Biophys Res Commun (1981) 0.93
Evolutionary relationships among bacterial carbamoyltransferases. J Gen Microbiol (1989) 0.92
Isolation and characterization of the cyanogen bromide peptides from the B fragment of diphtheria toxin. Biochim Biophys Acta (1978) 0.90
Human bronchoalveolar lavage fluid: two-dimensional gel electrophoresis, amino acid microsequencing and identification of major proteins. Electrophoresis (1999) 0.90
Purification and properties of a succinyltransferase from Pseudomonas aeruginosa specific for both arginine and ornithine. Eur J Biochem (1994) 0.90
Evidence for specific and non-covalent binding of lipids to natural and recombinant Mycobacterium bovis BCG hsp60 proteins, and to the Escherichia coli homologue GroEL. Microbiology (2000) 0.89
Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive immunoassay. Eur Respir J (1998) 0.87
Characterization of the interaction of IpaB and IpaD, proteins required for entry of Shigella flexneri into epithelial cells, with a lipid membrane. Eur J Biochem (2000) 0.87
Synthesis of Escherichia coli carbamoylphosphate synthetase initiates at a UUG codon. Eur J Biochem (1985) 0.86
Immune response to diphtheria toxin and to different CNBr fragments: evidence for different B and T cell reactivities. Eur J Immunol (1986) 0.85
Structure and interaction of PA63 and EF (edema toxin) of Bacillus anthracis with lipid membrane. Biochemistry (1997) 0.84
Tetanus toxin induces fusion and aggregation of lipid vesicles containing phosphatidylinositol at low pH. Biochem Biophys Res Commun (1985) 0.83
Expression of a biologically active diphtheria toxin fragment B in Escherichia coli. Mol Microbiol (1988) 0.83
Proteomics as the tool to search for lung disease markers in bronchoalveolar lavage. Dis Markers (2001) 0.82
Renal epidermal growth factor precursor: proteolytic processing in an in vitro cell-free system. Biochim Biophys Acta (1997) 0.82
Monoclonal B-cell response to diphtheria toxoid: evidence for cross-reactive epitopes. Immunology (1987) 0.82
pH-dependent bilayer destabilization and fusion of phospholipidic large unilamellar vesicles induced by diphtheria toxin and its fragments A and B. Biochemistry (1989) 0.81
Topology of diphtheria toxin in lipid vesicle membranes: a proteolysis study. Mol Microbiol (1996) 0.81
Characterization of human serum N-acetylmuramyl-L-alanine amidase purified by affinity chromatography. Protein Expr Purif (1995) 0.81
Diphtheria toxin induces fusion of small unilamellar vesicles at low pH. Biochim Biophys Acta (1984) 0.81
Immunological and structural relatedness of catabolic ornithine carbamoyltransferases and the anabolic enzymes of enterobacteria. J Bacteriol (1985) 0.80
[Purification and partial characterization of two malate synthases of Echerichia coli]. Eur J Biochem (1973) 0.80
Isolation and partial characterization of a pregnancy-associated glycoprotein family from the goat placenta. Biol Reprod (1998) 0.80
Use of a photoactivatable lipid to probe the topology of PA63 of Bacillus anthracis in lipid membranes. Eur J Biochem (1998) 0.79
Secondary structure changes of diphtheria toxin interacting with asolectin liposomes: an infrared spectroscopy study. Biochimie (1989) 0.79
Structure and topology of diphtheria toxin R domain in lipid membranes. Biochemistry (1999) 0.79
Modification of immunoreactive EGF and EGF receptor after acute tubular necrosis induced by tobramycin or cisplatin. Ren Fail (1994) 0.78
pH dependent insertion of a diphtheria toxin B fragment peptide into the lipid membrane: a conformational analysis. Biochem Biophys Res Commun (1986) 0.78
Purification and preliminary characterization of a frog-derived proteinaceous chemoattractant eliciting prey attack by checkered garter snakes (Thamnophis marcianus). J Chem Ecol (1994) 0.78
Maternal tobacco smoking and lung epithelium-specific proteins in amniotic fluid. Pediatr Res (2001) 0.78
Characterization of a cell line established from diethylstilbestrol-induced renal tumors in Syrian hamsters. In Vitro Cell Dev Biol Anim (1999) 0.77
Immunohistochemical analysis of diethylstilbestrol-induced renal tumors in adult male Syrian hamsters: evidence for relationship to peripheral nerve sheath tumors. Histochem Cell Biol (2001) 0.77
Sublethal alterations and sustained cell proliferation associated with the diethylstilbestrol-induced renal carcinogenesis in male Syrian golden hamsters. Eur J Morphol (1998) 0.77
Changes in protein expression in the vestibular nuclei during vestibular compensation. Neuroreport (1999) 0.77
Demonstration of estrogen receptors and of estrogen responsiveness in the HKT-1097 cell line derived from diethylstilbestrol-induced kidney tumors. In Vitro Cell Dev Biol Anim (2001) 0.77
Involvement of transforming growth factor-alpha and its receptor in a model of DES-induced renal carcinogenesis in the Syrian hamster. Carcinogenesis (1996) 0.75
Complete and N-terminal amino-acid sequences of CNBr-peptides CB5 and CB3 from diphteria toxin fragment B [proceedings]. Arch Int Physiol Biochim (1979) 0.75
In vitro demonstration of a mitogenic activity in renal tissue extracts during regenerative hyperplasia. Am J Physiol (1998) 0.75
Transforming growth factor-alpha and epidermal growth factor in hamster tissues: biochemical and immunohistochemical studies. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol (1995) 0.75
[Primary structure of fragment B of diphtheria toxin: peptides obtained by cleavage by cyanogen bromide]. Arch Int Physiol Biochim (1975) 0.75
[Primary structure of fragment B of diphtheria toxin: N-terminal residues and alignment of the CNBr peptides]. Arch Int Physiol Biochim (1976) 0.75
Apolipoprotein-like structure of the N-terminal amino-acid sequence of diphtheria toxin fragment B [proceedings]. Arch Int Physiol Biochim (1979) 0.75
Biophysical properties of diphtheria toxin fragment B in correlation to its binding ability to eukaryotic cell membranes [proceedings]. Arch Int Physiol Biochim (1979) 0.75
Aggregation and fusion of lipid vesicles induced by diphtheria toxin at low pH: possible involvement of the P site and the NAD+ binding site. Biosci Rep (1985) 0.75
[Isolation of peptides obtained by the action of cyanogen bromide on fragment A of diphtheria toxin]. Arch Int Physiol Biochim (1973) 0.75
[Presence of an amphipatic segment in the B fragment of diphtheria toxin (proceedings)]. Arch Int Physiol Biochim (1979) 0.75